Evidence map›Paper›PMID 31843200›Full record

ReviewCellular immunology2020

Aging, sex, inflammation, frailty, and CMV and HIV infections.

Sean X Leng, Joseph B Margolick

Open access · greenAbstract readReview
In one paragraph

Review in Cellular immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 65 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Epigenetic age acceleration and mortality among persons with poorly controlled HIV.The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. [Mechanism and significance of cell senescence induced by viral infection].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2025
    Review
  13. Article
  14. Review
  15. Article
  16. Toxoplasma gondii IgG Serointensity Is Positively Associated With Frailty.The journals of gerontology. Series A, Biological sciences and medical sciences · 2024
    Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Sean X LengDivision of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: sleng1@jhmi.edu.
Joseph B MargolickDepartment of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Johns Hopkins Medicine · USJohns Hopkins University · US

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Multicenter Aids Cohort Study- Part B (Baltimore Site)U01AI035042 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BROWN, TODD T, MARGOLICK, JOSEPH B. · 1993 to 2018
$61.5M
Clinical Research Sites for the MACS/WIHS Combined Cohort Study (MACS/WIHS-CCS) - Baltimore/Wash DC Center - Admin Supplement: Vision and dual sensory loss in HIV-infected older adultsU01HL146201 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI TODD T BROWN, Joseph B. Margolick · 2019 to 2026
$33.7M
Sex differences in the impact of frailty on vaccine-induced immune responses in community-dwelling older adultsU54AG062333 · NIA · JOHNS HOPKINS UNIVERSITY · PI KLEIN, SABRA L. · 2018 to 2022
$8.9M
Leveraging an ongoing longitudinal study of influenza vaccination to define immune signatures of response and risk of infection in older adults >75U01AI165826 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Sean Xiao Leng · 2022 to 2026
$8.2M
Influenza vaccine failure in adults over age 75: role of chronic CMV infectionR01AI108907 · NIAID · JOHNS HOPKINS UNIVERSITY · PI LENG, SEAN XIAO · 2014 to 2018
$2.8M
A Randomized, Blinded, Placebo-Controlled Clinical Trial to Evaluate Longeveron Mesenchymal Stem Cell (LMSC) Therapy for Treating The Metabolic SyndromeR42AG054322 · NIA · LONGEVERON, LLC · PI HARE, JOSHUA M, LENG, SEAN XIAO · 2017 to 2020
$1.1M
T-cell responses to CMV as a determinant of systemic immune activationR21AG059742 · NIA · JOHNS HOPKINS UNIVERSITY · PI LENG, SEAN XIAO, MARGOLICK, JOSEPH B. · 2019 to 2020
$450k
Chronic CMV infection in the elderly: diagnosis and link to chronic inflammationR21AG043874 · NIA · JOHNS HOPKINS UNIVERSITY · PI LENG, SEAN XIAO · 2013 to 2014
$446k
NHLBI NIH HHS U01 HL146201NIAID NIH HHS P30 AI094189NIAID NIH HHS R01 AI108907NIAID NIH HHS U01 AI035042NIAID NIH HHS U01 AI165826NIA NIH HHS R21 AG043874NIA NIH HHS R21 AG059742NIA NIH HHS R42 AG054322NIA NIH HHS U54 AG062333
6 · The paper itself

Abstract

Aging is characterized by significant immune remodeling at both cellular and molecular levels, also known as immunosenescence. Older adults often manifest a chronic low-grade inflammatory phenotype. These age-related immune system changes have increasingly been recognized not only to lead to immune functional decline and increased vulnerability to infections, but also to play an important role in many chronic conditions such as frailty in older adults. In addition to sex as an important biological factor, chronic viral infections including that by human immunodeficiency virus (HIV) and cytomegalovirus (CMV) are all known to have major impact on the aging immune system. This article provides an overview of our current understanding of aging immunity, sex, inflammation, frailty, and HIV and CMV infections.

Indexed as

AgedCytomegalovirus InfectionsFemaleFrailtyHIV InfectionsHumansImmunosenescenceInflammationMaleSex CharacteristicsAgingCLIPCMVFrailtyHIVImmunosenescenceSex

Identifiers

PMID31843200
PMCPMC7002257
OpenAlexW2991521894

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.